372 related articles for article (PubMed ID: 16611197)
1. Comparison of dynamic treatment regimes via inverse probability weighting.
Hernán MA; Lanoy E; Costagliola D; Robins JM
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):237-42. PubMed ID: 16611197
[TBL] [Abstract][Full Text] [Related]
2. Inverse probability-of-censoring weights for the correction of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident AIDS or death.
Cain LE; Cole SR
Stat Med; 2009 May; 28(12):1725-38. PubMed ID: 19347843
[TBL] [Abstract][Full Text] [Related]
3. Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study).
Yoshida M; Matsuyama Y; Ohashi Y;
Clin Trials; 2007; 4(4):318-28. PubMed ID: 17848493
[TBL] [Abstract][Full Text] [Related]
4. Demystifying optimal dynamic treatment regimes.
Moodie EE; Richardson TS; Stephens DA
Biometrics; 2007 Jun; 63(2):447-55. PubMed ID: 17688497
[TBL] [Abstract][Full Text] [Related]
5. Regression modeling of semicompeting risks data.
Peng L; Fine JP
Biometrics; 2007 Mar; 63(1):96-108. PubMed ID: 17447934
[TBL] [Abstract][Full Text] [Related]
6. Estimation for the optimal combination of markers without modeling the censoring distribution.
Chiang CT; Huang SY
Biometrics; 2009 Mar; 65(1):152-8. PubMed ID: 18422791
[TBL] [Abstract][Full Text] [Related]
7. Estimating lifetime or episode-of-illness costs under censoring.
Basu A; Manning WG
Health Econ; 2010 Sep; 19(9):1010-28. PubMed ID: 20665908
[TBL] [Abstract][Full Text] [Related]
8. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
9. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
Cozzi-Lepri A; Phillips AN; Clotet B; Mocroft A; Ruiz L; Kirk O; Lazzarin A; Wiercinska-Drapalo A; Karlsson A; Lundgren JD;
AIDS; 2008 Oct; 22(16):2187-98. PubMed ID: 18832882
[TBL] [Abstract][Full Text] [Related]
10. Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring weighted (IPCW) methods.
Matsuyama Y; Yamaguchi T
Pharm Stat; 2008; 7(3):202-14. PubMed ID: 17554753
[TBL] [Abstract][Full Text] [Related]
11. Modeling the short-, middle- and long-term viral load responses for comparing estimated dynamic parameters.
Huang Y
Biom J; 2007 Jun; 49(3):429-40. PubMed ID: 17623347
[TBL] [Abstract][Full Text] [Related]
12. Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias.
Howe CJ; Cole SR; Chmiel JS; Muñoz A
Am J Epidemiol; 2011 Mar; 173(5):569-77. PubMed ID: 21289029
[TBL] [Abstract][Full Text] [Related]
13. Selection Bias Due to Loss to Follow Up in Cohort Studies.
Howe CJ; Cole SR; Lau B; Napravnik S; Eron JJ
Epidemiology; 2016 Jan; 27(1):91-7. PubMed ID: 26484424
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous inference for longitudinal data with detection limits and covariates measured with errors, with application to AIDS studies.
Wu L
Stat Med; 2004 Jun; 23(11):1715-31. PubMed ID: 15160404
[TBL] [Abstract][Full Text] [Related]
15. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
Hogan JW; Lancaster T
Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
[TBL] [Abstract][Full Text] [Related]
16. Constructing inverse probability weights for marginal structural models.
Cole SR; Hernán MA
Am J Epidemiol; 2008 Sep; 168(6):656-64. PubMed ID: 18682488
[TBL] [Abstract][Full Text] [Related]
17. Fitting marginal structural models: estimating covariate-treatment associations in the reweighted data set can guide model fitting.
Pullenayegum EM; Lam C; Manlhiot C; Feldman BM
J Clin Epidemiol; 2008 Sep; 61(9):875-81. PubMed ID: 18486447
[TBL] [Abstract][Full Text] [Related]
18. Marginal structural models for case-cohort study designs to estimate the association of antiretroviral therapy initiation with incident AIDS or death.
Cole SR; Hudgens MG; Tien PC; Anastos K; Kingsley L; Chmiel JS; Jacobson LP
Am J Epidemiol; 2012 Mar; 175(5):381-90. PubMed ID: 22302074
[TBL] [Abstract][Full Text] [Related]
19. Marginal structural models for partial exposure regimes.
Vansteelandt S; Mertens K; Suetens C; Goetghebeur E
Biostatistics; 2009 Jan; 10(1):46-59. PubMed ID: 18503036
[TBL] [Abstract][Full Text] [Related]
20. Robust analysis of biomarker data with informative missingness using a two-stage hypothesis test in an HIV treatment interruption trial: AIEDRP AIN503/ACTG A5217.
Messer K; Vaida F; Hogan C
Contemp Clin Trials; 2006 Dec; 27(6):506-17. PubMed ID: 16962381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
